In accordance with the Food and Drug Administration's change order for pharmaceutical manufacturing (import) items (Permission Review and Coordination Division-No. 2150, effective date 2009.10.6), the precautions for use of Levamide tablets and the efficacy and dosage of Pyrosin tablets have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Levamide tablets, Pyrosin tablets
Attachments are original documents and may be in Korean. English editions are labeled separately.
Levamide tablets.hwpChange in Levamide tablets (precautions for use) (2009.10.06).hwp · 26 KBDownload ↓